Toujeo 300 U/mL

Toujeo 300 U/mL is a prescription injectable insulin containing Insulin Glargine, shown as a Sanofi product. It is a long-acting basal insulin used to help control high blood sugar in people with diabetes mellitus. Tiny cartridge, massive glucose-management responsibility, because apparently sugar needed a full-time supervisor.  Toujeo is indicated to improve glycemic control in adults and children aged 6 years and older with diabetes mellitus.

Composition:

Insulin Glargine – 300 Units/mL
Monocomponent Insulin Glargine, r-DNA origin

Key Information:

Brand Name: Toujeo
Strength: 300 U/mL
Active Ingredient: Insulin Glargine
Dosage Form: Solution for injection / cartridge
Medicine Type: Long-acting basal insulin
Manufacturer/Brand Shown: Sanofi
Common Use: Blood sugar control in diabetes mellitus
Administration: Subcutaneous injection
Category: Prescription medicine
Pack Type: Cartridge for TouStar pen, as visible on the pack

How It Works:

Toujeo works by providing a slow, steady release of insulin activity over time. Insulin glargine helps lower blood glucose by helping body cells take up sugar from the blood and by reducing glucose production from the liver. Toujeo contains 300 units of insulin glargine per mL, making it a concentrated insulin product.

Potential Indications:

• Type 1 diabetes mellitus
• Type 2 diabetes mellitus
• Long-acting basal insulin support
• Blood glucose control as part of a doctor-prescribed diabetes plan

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
Inject subcutaneously only. Do not inject into a vein or muscle unless specifically directed by medical protocol.
Do not remove insulin with a syringe from the cartridge/pen system, as visible on the pack warning.
Toujeo is generally used once daily, preferably at the same time each day, with dose adjusted according to individual blood sugar response.
Do not use Toujeo for diabetic ketoacidosis; short-acting intravenous insulin is preferred in that situation.
Store as per the physical label and cold-chain instructions. Keep out of reach of children.

Important Safety Information:

Toujeo should be used carefully under medical supervision, especially in patients with low blood sugar risk, kidney or liver problems, changes in diet/exercise, illness, pregnancy, or use of other diabetes medicines.

Possible side effects may include:

• Low blood sugar / hypoglycemia
• Injection-site redness, itching, swelling, or pain
• Weight gain
• Swelling/fluid retention
• Allergic reaction
• Low potassium levels
• Skin thickening or pits at injection site if sites are not rotated

Serious symptoms such as severe sweating, confusion, fainting, seizure, breathing difficulty, swelling of face/lips, severe rash, or very low blood sugar should be treated urgently.

Label Verification:

Please double-check the physical product label before listing or use, including product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, pen/cartridge compatibility, dosage directions, and route of administration.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.